kezar life sciences stock

No recent news for Kezar Life Sciences Inc. Kezar Life Sciences Inc.

Kezar Life Sciences Aktien News A2jpe7 Nachrichten

Rooms Shows Rankings Earnings Newsletters Shop.

. South san francisco calif april 15 2022--kezar life sciences inc nasdaq. SOUTH SAN FRANCISCO Calif-- BUSINESS WIRE--Kezar Life Sciences Inc. It discovers and develops molecule therapeutics and medicines such as protein homeostasis for autoimmune disorders.

The big gain came after the company announced interim results on Monday from a phase 2 study evaluating KZR-616 in treating autoimmune disease lupus nephritis. Is a bio-technology company. Find real-time KZR - Kezar Life Sciences Inc stock quotes company profile.

KZR Stock Price News Info The Motley Fool Our Services Investing Basics Premium Services Stock Advisor Our Flagship Service. Latest Kezar Life Sciences Inc KZR Stock News As of May 05 2022 Kezar Life Sciences Inc had a 4204 million market capitalization compared to the Biotechnology Medical Research median of 1216 million Kezar Life Sciences Incs stock is down 623 in 2022 down 469 in the previous five trading days and up 173 in the past year. The big gain came after the company announced interim results on Monday from a phase 2 study.

Kezar Life Sciences Inc. Kezar Life Sciences NASDAQKZR Get Rating had its price objective decreased by equities research analysts at Wells Fargo Company from 1900 to 1400 in a research note issued to investors on Wednesday The Fly reportsWells Fargo Companys target price would indicate a potential upside of 11705 from the stocks previous close. Kezar Life Sciences Inc.

4 months ago - Business Wire Why Kezar Life Sciences Stock Is Soaring Today The company reported promising results from a phase 2 study. Shares of Kezar Life Sciences KZR -292 were soaring 361 as of 1103 am. NASDAQKZR shares over.

Kezar Life Sciences Inc. It discovers and develops molecule therapeutics and medicines such as protein homeostasis for autoimmune disorders. Stock Price as of May 10 2022.

Real-time trade and investing ideas on Kezar Life Sciences Inc KZR from the largest community of traders and investors. 4000 Shoreline Court Suite 300 South San Francisco CA 94080. With the huge move for the biotech stock.

Kezar Life Sciences Inc. Some of the losses seen by insiders who purchased US13m worth of Kezar Life Sciences Inc. KZR were soaring 361 as of 1103 am.

KZR a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and o. Is a bio-technology company. Kezar Life Sciences Inc.

Kezar Life Sciences Stock Forecast Price News 631 -014 -217 As of 0562022 1200 AM ET Todays Range 613 651 50-Day Range 631 1833 52-Week Range 461 1855 Volume 182 million shs Average Volume 110 million shs Market Capitalization 35784 million PE Ratio NA Dividend Yield NA Beta 049 Profile Analyst Ratings. Kwhen Dec 28 2021. Is headquartered in South San Francisco California.

Is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco. Shares Out 6041M 10 Day Average Volume 153M Dividend - Dividend Yield - Beta 052 YTD Change -6226 RATIOSPROFITABILITY EPS TTM -104 PE TTM -609 Fwd PE. Kezar Life Sciences Inc Shares Near 52-Week High - Market Mover.

Shares of Kezar Life Sciences NASDAQ. Kezar Life Sciences Inc. Kezar Life Sciences Inc 631 014 217 Watch.

Kezar Life Sciences Inc a clinical-stage biotechnology company engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and. The companys product pipeline consists of KZR-616 which is in clinical stage. With analysts defining 1400-2200 as the low and high price targets we arrive at a consensus price target of 1850 for the trailing 12-month period.

View KZR predictions and other driverless cars portfolios. Investors Business Daily Stocks Mostly Higher As FedEx Biotech. Why Kezar Life Sciences Stock Is Soaring Today.

Kezar Life Sciences Inc. Stock Data SEC Filings Governance Latest News Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635 c 4 Apr 15 2022 View Press Release Kezar Reports. Kzr a clinical-stage biotechnology company discovering and developing breakthrough treatments for.

NASDAQKZR is a biotechnology firm that develops therapies using small molecules to target serious illnesses such as cancer and. Kezar Life Sciences Inc Registered Shs Stock KZR. NASDAQKZRs beta value is currently sitting at 052 while the Average True Range indicator is currently displaying 116.

Common Stock stock price and ETFs.

Why Kezar Life Sciences Shares Are Getting Hammered Benzinga